Skip to main content
    P

    PharmaCyte Biotech Inc (PMCB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.67
    -1.01 (-15.12%)

    Market Cap: $3.77M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    PharmaCyte Biotech Inc (PMCB) Earnings: Report Dates and Results

    Updated Sep 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    PharmaCyte Biotech (PMCB) is expected to report earnings on Dec 16, 2026. In the quarter ended Jul 31, 2026, PharmaCyte Biotech reported EPS of -$0.54. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    36%(4/11)
    Avg Surprise
    -37.06%

    Next Report

    PMCB has an expected report date of Dec 16, 2026.

    Earnings History

    Of the 11 quarters below that had an estimate, PMCB beat 4, missed 4 and matched 3. The widest gap in the table came in the quarter ended Jul 31, 2023, when EPS landed 297.14% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Jul 31, 2026-$0.54N/AN/AN/AN/AN/AN/AN/ASep 14, 2026
    Apr 30, 2026-$0.01N/AN/AN/AN/A-100.6%N/AN/AJul 1, 2026
    Jan 31, 2026-$0.17N/AN/AN/AN/AN/AN/AN/AMar 17, 2026
    Oct 31, 2025-$1.24N/AN/AN/AN/AN/AN/AN/ADec 18, 2025
    Jul 31, 2025-$1.23N/AN/AN/AN/A-164.7%N/AN/AAug 11, 2025
    Apr 30, 2025$1.58N/AN/AN/AN/AN/AN/AN/AJul 2, 2025
    Jan 31, 2025-$0.44N/AN/AN/AN/AN/AN/AN/AMar 17, 2025
    Oct 31, 2024-$0.39N/AN/AN/AN/AN/AN/AN/ADec 13, 2024
    Jul 31, 2024$1.90N/AN/AN/AN/AN/AN/A0 up, 0 downAug 13, 2024
    Apr 30, 2024-$0.32N/AN/AN/AN/AN/AN/AN/AJul 29, 2024
    Jan 31, 2024-$0.07-$0.07N/A0.00%In lineN/AN/A0 up, 0 downMar 18, 2024
    Oct 31, 2023-$0.26-$0.08N/A-222.00%MissN/AN/A0 up, 0 downDec 15, 2023
    Jul 31, 2023-$0.28-$0.07N/A-297.14%MissN/AN/A0 up, 0 downSep 18, 2023
    Apr 30, 2023-$0.01-$0.09N/A+91.67%BeatN/AN/A0 up, 0 downJul 31, 2023
    Jan 31, 2023-$0.04-$0.08N/A+49.75%BeatN/AN/A0 up, 0 downMar 16, 2023
    Oct 31, 2022-$0.09-$0.08N/A-14.25%MissN/AN/A0 up, 0 downDec 14, 2022
    Jul 31, 2022-$0.07-$0.07-$0.07 - -$0.070.00%In lineN/A10 up, 0 downSep 14, 2022
    Apr 30, 2022-$0.06-$0.04-$0.04 - -$0.04-50.00%MissN/A10 up, 0 downJul 28, 2022
    Jan 31, 2022-$0.04-$0.05-$0.05 - -$0.05+20.00%BeatN/A10 up, 0 downMar 15, 2022
    Oct 31, 2021-$0.06-$0.07N/A+14.29%BeatN/AN/AN/ADec 14, 2021
    Jul 31, 2021-$0.64-$0.64N/A0.00%In lineN/AN/AN/AAug 10, 2021
    Apr 30, 2021-$0.64N/AN/AN/AN/AN/AN/AN/AJun 30, 2021
    Jan 31, 2021-$0.61N/AN/AN/AN/AN/AN/AN/AMar 12, 2021
    Oct 31, 2020-$0.49N/AN/AN/AN/AN/AN/AN/ADec 11, 2020
    Jul 31, 2020-$0.62N/AN/AN/AN/AN/AN/AN/AAug 13, 2020
    Apr 30, 2020-$0.79N/AN/AN/AN/AN/AN/AN/AJul 1, 2020
    Jan 31, 2020-$0.72N/AN/AN/AN/AN/AN/AN/AMar 13, 2020
    Oct 31, 2019-$0.95N/AN/AN/AN/AN/AN/AN/ADec 23, 2019
    Jul 31, 2019-$1.21N/AN/AN/AN/AN/AN/AN/AAug 12, 2019
    Apr 30, 2019-$1.41N/AN/AN/AN/AN/AN/AN/AJul 3, 2019
    Jan 31, 2019-$1.49N/AN/AN/AN/AN/AN/AN/AMar 14, 2019
    Oct 31, 2018-$0.90N/AN/AN/AN/AN/AN/AN/ADec 14, 2018
    Jul 31, 2018-$1.44N/AN/AN/AN/AN/AN/AN/ASep 12, 2018
    Apr 30, 2018-$1.74N/AN/AN/AN/AN/AN/AN/AJul 20, 2018
    Jan 31, 2018-$1.94N/AN/AN/AN/AN/AN/AN/AMar 19, 2018
    Oct 31, 2017-$3.12N/AN/AN/AN/AN/AN/AN/ADec 14, 2017
    Jul 31, 2017-$2.80N/AN/AN/AN/AN/AN/AN/ASep 13, 2017
    Apr 30, 2017-$2.74N/AN/AN/AN/AN/AN/AN/AJul 27, 2017
    Jan 31, 2017-$8.76N/AN/AN/AN/AN/AN/AN/AMar 13, 2017
    Oct 31, 2016-$2.24N/AN/AN/AN/AN/AN/AN/ADec 2, 2016
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Apr 30, 2026 was -$2.65, after $2.66 the year before. It was -$15.45 for the year ended Apr 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Apr 30, 2026-$2.65-199.7%
    Apr 30, 2025$2.66N/A
    Apr 30, 2024-$0.92N/A
    Apr 30, 2023-$0.21N/A
    Apr 30, 2022-$0.80N/A
    Apr 30, 2021-$2.36N/A
    Apr 30, 2020-$3.67N/A
    Apr 30, 2019-$5.23N/A
    Apr 30, 2018-$9.60N/A
    Apr 30, 2017-$15.45N/A

    Frequently Asked Questions About PMCB

    When is PharmaCyte Biotech's next earnings date?

    PharmaCyte Biotech's next earnings report is expected for Dec 16, 2026.

    How often does PMCB beat earnings estimates?

    PharmaCyte Biotech beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -55.25%.